• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

资源匮乏国家的 COVID-19 综合防控。

Integrated control of COVID-19 in resource-poor countries.

机构信息

International Center for Diarrheal Disease Research, Dhaka, Bangladesh.

International Center for Diarrheal Disease Research, Dhaka, Bangladesh; Menzies Health Institute Queensland, Gold Coast, Australia.

出版信息

Int J Infect Dis. 2020 Dec;101:98-101. doi: 10.1016/j.ijid.2020.09.009. Epub 2020 Sep 9.

DOI:10.1016/j.ijid.2020.09.009
PMID:32916249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7480448/
Abstract

Low- and middle-income countries (LMICs) face many challenges in controlling COVID-19. Healthcare resources are limited and so are ICU beds. RT-PCR testing is conducted on a limited scale and treatment options are few. There is no vaccine. Therefore, what low-cost solutions remain for the prevention, diagnosis, and treatment of SARS-CoV-2? How should these essential health services be delivered in order to reach the most vulnerable in our societies? In this editorial we discuss several important strategies for controlling COVID-19 including: vaccination, molecular and serological diagnostics, hygiene and WaSH interventions, and low-cost therapeutics. We also discuss the delivery of such services in order to reach the most in need. The proposed integrated control strategy requires immediate action and political will in order to reduce the widening health inequalities caused by the pandemic.

摘要

中低收入国家(LMICs)在控制 COVID-19 方面面临许多挑战。医疗保健资源有限,重症监护病床也有限。RT-PCR 检测规模有限,治疗选择也很少。没有疫苗。那么,用于预防、诊断和治疗 SARS-CoV-2 的低成本解决方案还有哪些?为了帮助我们社会中最脆弱的人群,应该如何提供这些基本的卫生服务?在这篇社论中,我们讨论了控制 COVID-19 的几种重要策略,包括:疫苗接种、分子和血清学诊断、卫生和水环境卫生干预以及低成本疗法。我们还讨论了提供这些服务的方式,以帮助最需要的人。为了减少大流行造成的日益扩大的健康不平等,所提出的综合控制策略需要立即采取行动和政治意愿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547e/7480448/994363ace6e3/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547e/7480448/a31aedf9c42b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547e/7480448/2ca379a247ab/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547e/7480448/994363ace6e3/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547e/7480448/a31aedf9c42b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547e/7480448/2ca379a247ab/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547e/7480448/994363ace6e3/gr3_lrg.jpg

相似文献

1
Integrated control of COVID-19 in resource-poor countries.资源匮乏国家的 COVID-19 综合防控。
Int J Infect Dis. 2020 Dec;101:98-101. doi: 10.1016/j.ijid.2020.09.009. Epub 2020 Sep 9.
2
Tuberculosis结核病
3
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
4
Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.健康工作者接种一剂 SARS-CoV-2 疫苗后,使用六种自动化 SARS-CoV-2 抗体检测试剂的血清学反应。
Diagn Microbiol Infect Dis. 2021 Oct;101(2):115486. doi: 10.1016/j.diagmicrobio.2021.115486. Epub 2021 Jul 10.
5
SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.SARS-CoV-2 mRNA 疫苗在免疫原性初免和预免疫人群中引发不同的反应。
Front Immunol. 2021 Sep 27;12:728021. doi: 10.3389/fimmu.2021.728021. eCollection 2021.
6
Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.用于评估接种后 SARS-CoV-2 抗体反应的血清学检测方法。
Microbiol Spectr. 2021 Oct 31;9(2):e0073321. doi: 10.1128/Spectrum.00733-21. Epub 2021 Sep 29.
7
The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.用于检测SARS-CoV-2免疫的抗体检测的科学缺陷。
JAMA. 2021 Nov 9;326(18):1781-1782. doi: 10.1001/jama.2021.18919.
8
COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa.COVID-19 应对准备:撒哈拉以南非洲地区疫苗、疗法和诊断试剂的生产能力。
Global Health. 2021 Mar 3;17(1):24. doi: 10.1186/s12992-021-00668-6.
9
Multicomponent Strategies to Prevent SARS-CoV-2 Transmission - Nine Overnight Youth Summer Camps, United States, June-August 2021.多组分策略预防 SARS-CoV-2 传播——2021 年 6 月至 8 月,美国九个青少年夏令营。
MMWR Morb Mortal Wkly Rep. 2021 Oct 8;70(40):1420-1424. doi: 10.15585/mmwr.mm7040e1.
10
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.

引用本文的文献

1
A Narrative Review on the Pandemic Zoonotic RNA Virus Infections Occurred During the Last 25 Years.关于过去25年中发生的大流行性人畜共患RNA病毒感染的叙述性综述。
J Epidemiol Glob Health. 2024 Dec;14(4):1397-1412. doi: 10.1007/s44197-024-00304-7. Epub 2024 Oct 8.
2
Vaccine effectiveness against emerging COVID-19 variants using digital health data.利用数字健康数据评估疫苗对新出现的新冠病毒变体的有效性。
Commun Med (Lond). 2024 May 6;4(1):81. doi: 10.1038/s43856-024-00508-9.
3
Study of Biochemical Parameters as Predictors for Need of Invasive Ventilation in Severely Ill COVID-19 Patients.

本文引用的文献

1
COVID-19 vaccine trials should seek worthwhile efficacy.新冠病毒疫苗试验应追求有价值的疗效。
Lancet. 2020 Sep 12;396(10253):741-743. doi: 10.1016/S0140-6736(20)31821-3. Epub 2020 Aug 27.
2
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.腺病毒载体新冠疫苗(ChAdOx1 nCoV-19)对严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)的安全性和免疫原性:一项 1/2 期、单盲、随机对照临床试验的初步报告。
Lancet. 2020 Aug 15;396(10249):467-478. doi: 10.1016/S0140-6736(20)31604-4. Epub 2020 Jul 20.
3
Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19.
新冠重症患者生化指标作为有创通气需求预测指标的研究
J Crit Care Med (Targu Mures). 2023 Nov 14;9(4):262-270. doi: 10.2478/jccm-2023-0030. eCollection 2023 Oct.
4
Elucidating the role of environmental management of forests, air quality, solid waste and wastewater on the dissemination of SARS-CoV-2.阐明森林环境管理、空气质量、固体废物和废水管理对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播的作用。
Hyg Environ Health Adv. 2022 Sep;3:100006. doi: 10.1016/j.heha.2022.100006. Epub 2022 May 10.
5
Using low-cost disposable immunosensor based on flexible PET screen-printed electrode modified with carbon black and gold nanoparticles for sensitive detection of SARS-CoV-2.使用基于柔性聚对苯二甲酸乙二酯丝网印刷电极、用炭黑和金纳米颗粒修饰的低成本一次性免疫传感器,用于灵敏检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)。
Talanta Open. 2023 Aug;7:100201. doi: 10.1016/j.talo.2023.100201. Epub 2023 Mar 10.
6
Differences between Rural and Urban Practices in the Response to the COVID-19 Pandemic: Outcomes from the PRICOV-19 Study in 38 Countries.农村和城市应对 COVID-19 大流行措施的差异:38 个国家 PRICOV-19 研究的结果。
Int J Environ Res Public Health. 2023 Feb 19;20(4):3674. doi: 10.3390/ijerph20043674.
7
Contribution of PEPFAR-Supported HIV and TB Molecular Diagnostic Networks to COVID-19 Testing Preparedness in 16 Countries.PEPFAR 支持的艾滋病毒和结核病分子诊断网络对 16 个国家新冠病毒检测准备工作的贡献。
Emerg Infect Dis. 2022 Dec;28(13):S59-S68. doi: 10.3201/eid2813.220789.
8
Heterogeneity of the COVID-19 epidemic: what can we learn from it?新冠疫情的异质性:我们能从中吸取什么教训?
Am J Transl Res. 2022 Oct 15;14(10):6846-6855. eCollection 2022.
9
A Qualitative Evaluation of COVID-19 Preventative Response Activities in South Kivu, Democratic Republic of the Congo.刚果民主共和国南基伍省 COVID-19 预防应对活动的定性评估。
Int J Environ Res Public Health. 2022 Oct 17;19(20):13424. doi: 10.3390/ijerph192013424.
10
Safety and immunogenicity of heterologous COVID-19 vaccine regimens to deal with product shortage: A randomised clinical trial in an elderly population.应对产品短缺的异源新型冠状病毒疫苗接种方案的安全性和免疫原性:一项针对老年人群的随机临床试验
Public Health Pract (Oxf). 2022 Dec;4:100313. doi: 10.1016/j.puhip.2022.100313. Epub 2022 Sep 6.
临床评价:定量逆转录实时聚合酶链反应(RT-qPCR)、直接 RT-qPCR、逆转录环介导等温扩增和快速抗原检测在诊断 COVID-19 中的应用。
J Clin Microbiol. 2020 Aug 24;58(9). doi: 10.1128/JCM.01438-20.
4
Covid-19: Oxford team begins vaccine trials in Brazil and South Africa to determine efficacy.新冠疫情:牛津团队在巴西和南非开展疫苗试验以确定疗效。
BMJ. 2020 Jun 29;369:m2612. doi: 10.1136/bmj.m2612.
5
Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review.粪便中 SARS-CoV-2 的持续病毒脱落——快速综述。
Colorectal Dis. 2020 Jun;22(6):611-620. doi: 10.1111/codi.15138. Epub 2020 Jun 4.
6
COVID-19: The environmental implications of shedding SARS-CoV-2 in human faeces.新型冠状病毒肺炎:人类粪便中新型冠状病毒脱落对环境的影响
Environ Int. 2020 Jul;140:105790. doi: 10.1016/j.envint.2020.105790. Epub 2020 May 6.
7
Diagnostic performance of COVID-19 serology assays.新型冠状病毒肺炎血清学检测的诊断性能
Malays J Pathol. 2020 Apr;42(1):13-21.
8
Presumed Asymptomatic Carrier Transmission of COVID-19.新冠病毒无症状感染者的传播。
JAMA. 2020 Apr 14;323(14):1406-1407. doi: 10.1001/jama.2020.2565.
9
Can we 'WaSH' infectious diseases out of slums?贫民窟能否通过“冲洗”来消灭传染病?
Int J Infect Dis. 2020 Mar;92:130-132. doi: 10.1016/j.ijid.2020.01.014. Epub 2020 Jan 18.
10
Effectiveness of personal protective measures in reducing pandemic influenza transmission: A systematic review and meta-analysis.个人防护措施在降低大流行性流感传播中的效果:系统评价和荟萃分析。
Epidemics. 2017 Sep;20:1-20. doi: 10.1016/j.epidem.2017.04.003. Epub 2017 Apr 30.